earnings
CL
NASDAQ · CLGN
CollPlant Biotechnologies Ltd.
Healthcare · Biotechnology
$4.64
Up+$0.68 (+17.17%)
Updated Nov 17, 2026, 7:17 AM
SID Score
5.6/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 23.78M
- P/E ratio
- -1.96
- Dividend yield
- 0.00%
- 52-week range
- $0.26 – $9.60
- Volume
- 439.3K
- Avg. volume
- 99.32K
Price performance · CLGN
CLGN price history
1M range · 19 trading sessions · Daily adjusted prices
Prices through Nov 12, 2026
CLGN closed at $4.64 after 19 trading sessions, up 30.34% for the selected period.
- Last close
- $4.64
- Period change
- +30.34%
- Period low
- $3.56
- Period high
- $4.64
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 12, 2026 | $4.05 | $4.64 | $4.05 | $4.64 | 439.3K |
| Nov 11, 2026 | $4.0254 | $4.1999 | $3.86 | $3.96 | 25.05K |
| Nov 10, 2026 | $4.15 | $4.15 | $3.86 | $3.905 | 22.14K |
| Nov 9, 2026 | $4.00 | $4.29 | $3.7622 | $4.29 | 23.99K |
| Nov 6, 2026 | $4.18 | $4.1895 | $3.85 | $3.97 | 29.22K |
| Nov 5, 2026 | $4.13 | $4.25 | $3.94 | $3.94 | 100.47K |
| Nov 4, 2026 | $4.19 | $4.50 | $4.08 | $4.23 | 36.18K |
| Nov 3, 2026 | $4.01 | $4.4399 | $3.99 | $4.11 | 22.97K |
| Nov 2, 2026 | $4.15 | $4.20 | $3.95 | $4.08 | 40.5K |
| Oct 30, 2026 | $4.20 | $4.60 | $4.10 | $4.135 | 44.25K |
| Oct 29, 2026 | $4.10 | $4.70 | $3.8701 | $4.40 | 167.1K |
| Oct 28, 2026 | $3.87 | $4.00 | $3.75 | $3.95 | 9.25K |
| Oct 27, 2026 | $3.78 | $3.96 | $3.63 | $3.90 | 38.04K |
| Oct 26, 2026 | $3.67 | $3.91 | $3.65 | $3.75 | 33.81K |
| Oct 23, 2026 | $3.60 | $3.72 | $3.52 | $3.67 | 12.1K |
| Oct 22, 2026 | $3.71 | $3.74 | $3.41 | $3.62 | 10.6K |
| Oct 21, 2026 | $3.80 | $3.81 | $3.551 | $3.755 | 9.68K |
| Oct 20, 2026 | $3.5703 | $3.88 | $3.5302 | $3.88 | 20.36K |
| Oct 19, 2026 | $3.62 | $3.68 | $3.45 | $3.56 | 28.97K |
Latest CLGN news
The latest Smart Investors Daily articles mentioning CLGN.
Stock researchCompany · Earnings
Company
Market Activity
Research & News
Loading stock research…

